financetom
Business
financetom
/
Business
/
SeaStar Medical Begins Commercial Sale of Pediatric Acute Kidney Injury Treatment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SeaStar Medical Begins Commercial Sale of Pediatric Acute Kidney Injury Treatment
Jul 12, 2024 6:46 AM

09:28 AM EDT, 07/12/2024 (MT Newswires) -- SeaStar Medical ( ICU ) reported Friday the first commercial sale of the Quelimmune pediatric product to its US distribution partner Nuwellis ( NUWE ) .

The company said the US Food and Drug Administration has approved the device for treating pediatric acute kidney injury in patients weighing at least 10 kilograms and suffering from sepsis or similar conditions.

Shares of SeaStar were up 3.1% in recent Friday premarket activity while Nuwellis ( NUWE ) shares were down 1.5%.

Price: 7.90, Change: +0.24, Percent Change: +3.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved